395 related articles for article (PubMed ID: 11306456)
21. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
22. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues.
Arai E; Kanai Y; Ushijima S; Fujimoto H; Mukai K; Hirohashi S
Int J Cancer; 2006 Jul; 119(2):288-96. PubMed ID: 16453286
[TBL] [Abstract][Full Text] [Related]
23. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
24. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas.
Deng DJ; Zhou J; Zhu BD; Ji JF; Harper JC; Powell SM
World J Gastroenterol; 2003 Jan; 9(1):26-9. PubMed ID: 12508345
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability.
Sakata K; Tamura G; Endoh Y; Ohmura K; Ogata S; Motoyama T
Br J Cancer; 2002 Feb; 86(4):564-7. PubMed ID: 11870538
[TBL] [Abstract][Full Text] [Related]
26. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype.
Endoh Y; Tamura G; Ajioka Y; Watanabe H; Motoyama T
Am J Pathol; 2000 Sep; 157(3):717-22. PubMed ID: 10980110
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
28. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients.
Yuasa Y; Nagasaki H; Akiyama Y; Sakai H; Nakajima T; Ohkura Y; Takizawa T; Koike M; Tani M; Iwai T; Sugihara K; Imai K; Nakachi K
Carcinogenesis; 2005 Jan; 26(1):193-200. PubMed ID: 15498792
[TBL] [Abstract][Full Text] [Related]
29. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Ueki T; Toyota M; Sohn T; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2000 Apr; 60(7):1835-9. PubMed ID: 10766168
[TBL] [Abstract][Full Text] [Related]
32. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
33. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
[TBL] [Abstract][Full Text] [Related]
34. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer.
Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Hinoda Y; Imai K
Int J Cancer; 1999 Oct; 83(3):309-13. PubMed ID: 10495421
[TBL] [Abstract][Full Text] [Related]
35. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability.
Leung SY; Yuen ST; Chung LP; Chu KM; Chan AS; Ho JC
Cancer Res; 1999 Jan; 59(1):159-64. PubMed ID: 9892201
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.
Homma N; Tamura G; Honda T; Jin Z; Ohmura K; Kawata S; Motoyama T
Virchows Arch; 2005 Feb; 446(2):120-6. PubMed ID: 15735977
[TBL] [Abstract][Full Text] [Related]
37. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
38. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.
Tamura G
World J Gastroenterol; 2006 Jan; 12(2):192-8. PubMed ID: 16482617
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
